Related Experiment Video
Updated: Aug 23, 2026

A Mouse Fetal Skin Model of Scarless Wound Repair
Published on: January 16, 2015
Aplasia cutis congenita after methimazole exposure in utero
Eszter Karg1, Edit Bereg, Laszlo Gaspar
1Department of Pediatrics, University of Szeged, Albert Szent-Gyorgyi Medical School, Szeged, Hungary. karg@pedia.szote.u-szeged.hu
We describe a patient who was exposed to the antithyroid drug methimazole during the first 6 weeks of gestation and was born prematurely with scalp and skull defects associated with facial asymmetry. A review of the literature seems to support the hypothesis that methimazole is a potential teratogen. Although the risk of birth defects is low with clinically applied doses of the drug, it cannot be regarded as safe and should therefore be avoided in the treatment of pregnant women.
We describe a patient who was exposed to the antithyroid drug methimazole during the first 6 weeks of gestation and was born prematurely with scalp and skull defects associated with facial asymmetry. A review of the literature seems to support the hypothesis that methimazole is a potential teratogen. Although the risk of birth defects is low with clinically applied doses of the drug, it cannot be regarded as safe and should therefore be avoided in the treatment of pregnant women.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Acne Infection
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cellular Adaptation IV: Dysplasia and Metaplasia
Clinical Applications of Epidermal Stem Cells
